Evidence map›Paper›PMID 32511751›Full record

ArticleEuropean journal of clinical investigation2020

SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.

Federico Carbone, Fabrizio Montecucco, Marcel Twickler

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Role of LL-37 in thrombotic complications in patients with COVID-19.Cellular and molecular life sciences : CMLS · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Federico CarboneFirst Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0003-2957-4078
Fabrizio MontecuccoIRCCS Ospedale Policlinico San Martino Genoa - Italian Cardiovascular Network, Genoa, Italy.ORCID https://orcid.org/0000-0003-0823-8729
Marcel TwicklerDepartment of Endocrinology, Diabetology and Metabolic Diseases, Faculty of Medicine and Health Sciences, Deurne/Antwerp University of Antwerp, Antwerp, Belgium.ORCID https://orcid.org/0000-0001-8738-207X

Funding

Fondazione CarigeItalian Ministry of Health 2754291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticoagulantsBetacoronavirusBlood Coagulation DisordersCoronavirus InfectionsCOVID-19Disseminated Intravascular CoagulationEndothelium, VascularFibrin Fibrinogen Degradation ProductsHeparinHeparin, Low-Molecular-WeightHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipid MetabolismPandemicsPneumonia, ViralProthrombin TimeAnticoagulantsFibrin Fibrinogen Degradation Productsfibrin fragment DHeparinHeparin, Low-Molecular-WeightHydroxymethylglutaryl-CoA Reductase InhibitorsTriglycerides

Identifiers

PMID32511751
PMCPMC7300477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.